ViaCyte viacyte.com


Public list: Smart Money VCs (6328) Pharma Startups (4732)

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a therapy for the treatment of diabetes. The Company's lead product is based on the production of pancreatic progenitors derived from human pluripotent stem cells. These cells are implanted in a durable and retrievable encapsulation device. Once implanted and matured, these cells are designed to secrete insulin and other regulatory factors in response to blood glucose levels....Show all

ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a therapy for the treatment of diabetes. The Company's lead product is based on the production of pancreatic progenitors derived...Show all

Company (Alive / Active)

Phone: 858-455-3708

Fax:

3550 General Atomics Court

San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ViaCyte $135.4M Sep 25, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ViaCyte Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors

Competitors

Company Status Description Investors

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details

IRX Therapeutics

New York, New York, United States
AcquiredIRX Therapeutics develops immune therapies to treat cancer and related diseases. The company's therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and targeted therapeutics. The Company's product platform under development seeks to restore the immune system of cancer patients, which is suppressed by the onset of the disease.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cell compositions derived from dedifferentiated reprogrammed cells Jul 07, 2015 May 29, 2018 Patent
Methods of producing pancreatic hormones Mar 26, 2015 May 29, 2018 Patent
Encapsulation of pancreatic cells derived from human pluripotent stem cells Nov 13, 2015 Mar 13, 2018 Patent
Encapsulation of pancreatic cells derived from human pluripotent stem cells Aug 07, 2015 Sep 19, 2017 Patent
Preprimitive streak and mesendoderm cells Jul 25, 2011 Aug 15, 2017 Patent
See all 97 patents